stoxline Quote Chart Rank Option Currency Glossary
Enliven Therapeutics, Inc. (ELVN)
11.225  -0.275 (-2.39%)    12-05 11:03
Open: 11.38
High: 12.095
Volume: 38,473
Pre. Close: 11.5
Low: 11.2
Market Cap: 463(M)
Technical analysis
2023-12-05 10:45:29 AM
Short term     
Mid term     
Targets 6-month :  14.02 1-year :  15.48
Resists First :  12 Second :  13.25
Pivot price 11.18
Supports First :  9.98 Second :  8.3
MAs MA(5) :  11.52 MA(20) :  11.32
MA(100) :  14.56 MA(250) :  14.67
MACD MACD :  -0.3 Signal :  -0.4
%K %D K(14,3) :  62.9 D(3) :  57.9
RSI RSI(14): 46.9
52-week High :  24.79 Low :  3.63
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ELVN ] has closed below upper band by 37.7%. Bollinger Bands are 32.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 11.88 - 11.94 11.94 - 11.99
Low: 11.08 - 11.14 11.14 - 11.19
Close: 11.41 - 11.51 11.51 - 11.59
Company Description

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.

Headline News

Thu, 09 Nov 2023
Enliven Therapeutics Reports Third Quarter 2023 Financial Results ... - Yahoo Finance

Mon, 06 Nov 2023
Enliven Therapeutics Insider Sold Shares Worth $111751 ... -

Mon, 23 Oct 2023
ESMO 2023: New approaches to old targets, including HER2 and p53 - BioWorld Online

Thu, 17 Aug 2023
7 A-Rated Biotech Stocks for Your August Buy List - InvestorPlace

Thu, 10 Aug 2023
Fairmount Funds Management LLC Acquires New Stake in Kiniksa ... - Yahoo Finance

Tue, 23 May 2023
Peter Kolchinsky-led RA Capital's New Positions Feature CureVac ... - Nasdaq

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 41 (M)
Shares Float 11 (M)
Held by Insiders 7 (%)
Held by Institutions 85.9 (%)
Shares Short 5,220 (K)
Shares Short P.Month 5,100 (K)
Stock Financials
EPS -0.93
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 6.34
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -23.9 %
Return on Equity (ttm) -36 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.69
Qtrly Earnings Growth 0 %
Operating Cash Flow -57 (M)
Levered Free Cash Flow -31 (M)
Stock Valuations
PE Ratio -12.4
PEG Ratio 0
Price to Book value 1.79
Price to Sales 0
Price to Cash Flow -8.26
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android